Loading…
Right ventricular systolic function in hypertensive heart failure
Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor...
Saved in:
Published in: | Vascular health and risk management 2017-01, Vol.13, p.353-360 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423 |
---|---|
cites | |
container_end_page | 360 |
container_issue | |
container_start_page | 353 |
container_title | Vascular health and risk management |
container_volume | 13 |
creator | Oketona, O A Balogun, M O Akintomide, A O Ajayi, O E Adebayo, R A Mene-Afejuku, T O Oketona, O T Bamikole, O J |
description | Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor of adverse outcomes in HF. This study aimed to determine the prevalence of RV systolic dysfunction in HHF by several echocardiographic parameters.
One hundred subjects with HHF were recruited consecutively into the study along with 50 age and sex-matched controls. All study participants gave written informed consent, and had a full physical examination, blood investigations, 12-lead electrocardiogram, and transthoracic echocardiography. RV systolic function was assessed in all subjects using different methods based on the American Society of Echocardiography guidelines for echocardiographic assessment of the right heart in adults. This included tricuspid annular plane systolic excursion (TAPSE), RV myocardial performance index (MPI), and RV systolic excursion velocity by tissue Doppler (S').
RV systolic dysfunction was found in 53% of subjects with HHF by TAPSE, 56% by RV MPI, and 48% by tissue Doppler systolic excursion S'. RV systolic dysfunction increased with reducing left ventricular ejection fraction (LVEF) in subjects with HHF.
A high proportion of subjects with HHF were found to have RV systolic functional abnormalities using TAPSE, RV MPI, and RV S'. Prevalence of RV systolic dysfunction increased with reducing LVEF. |
doi_str_mv | 10.2147/VHRM.S142429 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_456cdac7de5b4b4780f92333fa11e7a1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A535420919</galeid><doaj_id>oai_doaj_org_article_456cdac7de5b4b4780f92333fa11e7a1</doaj_id><sourcerecordid>A535420919</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423</originalsourceid><addsrcrecordid>eNptktuLEzEUxgdR3HX1zWcZEMQHW3OdTF6Esqi7sCKsl9eQyZy0KWlSk5lC_3szti6tSB4STn75ci5fVb3EaE4wE-9_3tx_mX_DjDAiH1WXGIt2RhBrH5-cL6pnOa8R4k2L8NPqgkhEKRftZbW4d8vVUO8gDMmZ0etU530eonemtmMwg4uhdqFe7beQBgjZ7aBegU5DbbXzY4Ln1ROrfYYXx_2q-vHp4_frm9nd18-314u7meGiGWaYW6Fb29EGN1wyS3VDwPZIEGF62UmmeSdQp0tqPcgeDO046YTEHIGWjNCr6vag20e9VtvkNjrtVdRO_QnEtFQlK2c8KMYb02sjeuAd65hokZWEUmo1xiA0LlofDlrbsdtAb6bqtT8TPb8JbqWWcad4Q1qBUBF4exRI8dcIeVAblw14rwPEMSssOeYNJVIU9PU_6DqOKZRWKUIKgIUUJ9RSlwJcsLH8ayZRteCUM4IkloWa_4cqq4eNMzGAdSV-9uDNyYMyNz-scvTjNNZ8Dr47gCbFnBPYh2ZgpCafqcln6uizgr86beAD_NdY9DcaQ8wn</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229717977</pqid></control><display><type>article</type><title>Right ventricular systolic function in hypertensive heart failure</title><source>Taylor & Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central(OpenAccess)</source><creator>Oketona, O A ; Balogun, M O ; Akintomide, A O ; Ajayi, O E ; Adebayo, R A ; Mene-Afejuku, T O ; Oketona, O T ; Bamikole, O J</creator><creatorcontrib>Oketona, O A ; Balogun, M O ; Akintomide, A O ; Ajayi, O E ; Adebayo, R A ; Mene-Afejuku, T O ; Oketona, O T ; Bamikole, O J</creatorcontrib><description>Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor of adverse outcomes in HF. This study aimed to determine the prevalence of RV systolic dysfunction in HHF by several echocardiographic parameters.
One hundred subjects with HHF were recruited consecutively into the study along with 50 age and sex-matched controls. All study participants gave written informed consent, and had a full physical examination, blood investigations, 12-lead electrocardiogram, and transthoracic echocardiography. RV systolic function was assessed in all subjects using different methods based on the American Society of Echocardiography guidelines for echocardiographic assessment of the right heart in adults. This included tricuspid annular plane systolic excursion (TAPSE), RV myocardial performance index (MPI), and RV systolic excursion velocity by tissue Doppler (S').
RV systolic dysfunction was found in 53% of subjects with HHF by TAPSE, 56% by RV MPI, and 48% by tissue Doppler systolic excursion S'. RV systolic dysfunction increased with reducing left ventricular ejection fraction (LVEF) in subjects with HHF.
A high proportion of subjects with HHF were found to have RV systolic functional abnormalities using TAPSE, RV MPI, and RV S'. Prevalence of RV systolic dysfunction increased with reducing LVEF.</description><identifier>ISSN: 1178-2048</identifier><identifier>ISSN: 1176-6344</identifier><identifier>EISSN: 1178-2048</identifier><identifier>DOI: 10.2147/VHRM.S142429</identifier><identifier>PMID: 29033578</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Aged ; Beta blockers ; Blood pressure ; Cardiovascular disease ; Care and treatment ; Case-Control Studies ; Complications and side effects ; Cross-Sectional Studies ; Development and progression ; Echocardiography ; Echocardiography, Doppler ; Electrocardiography ; Female ; Health care ; Heart failure ; Heart Failure - diagnosis ; Heart Failure - epidemiology ; Heart Failure - physiopathology ; Humans ; Hypertension ; Hypertension - diagnostic imaging ; Hypertension - epidemiology ; Hypertension - physiopathology ; Male ; Medical examination ; Medical prognosis ; Medicine ; Methods ; Middle Aged ; Morphology ; Nigeria - epidemiology ; Original Research ; Prevalence ; Prognosis ; Right heart ventricle ; Right ventricle ; RV MPI ; RV S ; Stroke Volume ; Systole ; systolic function ; TAPSE ; Teaching hospitals ; Ultrasonic imaging ; Ventricular Dysfunction, Right - diagnosis ; Ventricular Dysfunction, Right - epidemiology ; Ventricular Dysfunction, Right - physiopathology ; Ventricular Function, Left ; Ventricular Function, Right</subject><ispartof>Vascular health and risk management, 2017-01, Vol.13, p.353-360</ispartof><rights>COPYRIGHT 2017 Dove Medical Press Limited</rights><rights>2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Oketona et al. This work is published and licensed by Dove Medical Press Limited 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423</citedby><orcidid>0000-0001-9107-8476 ; 0000-0001-5205-9344 ; 0000-0003-4993-0789</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2229717977/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2229717977?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29033578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oketona, O A</creatorcontrib><creatorcontrib>Balogun, M O</creatorcontrib><creatorcontrib>Akintomide, A O</creatorcontrib><creatorcontrib>Ajayi, O E</creatorcontrib><creatorcontrib>Adebayo, R A</creatorcontrib><creatorcontrib>Mene-Afejuku, T O</creatorcontrib><creatorcontrib>Oketona, O T</creatorcontrib><creatorcontrib>Bamikole, O J</creatorcontrib><title>Right ventricular systolic function in hypertensive heart failure</title><title>Vascular health and risk management</title><addtitle>Vasc Health Risk Manag</addtitle><description>Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor of adverse outcomes in HF. This study aimed to determine the prevalence of RV systolic dysfunction in HHF by several echocardiographic parameters.
One hundred subjects with HHF were recruited consecutively into the study along with 50 age and sex-matched controls. All study participants gave written informed consent, and had a full physical examination, blood investigations, 12-lead electrocardiogram, and transthoracic echocardiography. RV systolic function was assessed in all subjects using different methods based on the American Society of Echocardiography guidelines for echocardiographic assessment of the right heart in adults. This included tricuspid annular plane systolic excursion (TAPSE), RV myocardial performance index (MPI), and RV systolic excursion velocity by tissue Doppler (S').
RV systolic dysfunction was found in 53% of subjects with HHF by TAPSE, 56% by RV MPI, and 48% by tissue Doppler systolic excursion S'. RV systolic dysfunction increased with reducing left ventricular ejection fraction (LVEF) in subjects with HHF.
A high proportion of subjects with HHF were found to have RV systolic functional abnormalities using TAPSE, RV MPI, and RV S'. Prevalence of RV systolic dysfunction increased with reducing LVEF.</description><subject>Aged</subject><subject>Beta blockers</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Case-Control Studies</subject><subject>Complications and side effects</subject><subject>Cross-Sectional Studies</subject><subject>Development and progression</subject><subject>Echocardiography</subject><subject>Echocardiography, Doppler</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Health care</subject><subject>Heart failure</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - epidemiology</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - diagnostic imaging</subject><subject>Hypertension - epidemiology</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Medical examination</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Morphology</subject><subject>Nigeria - epidemiology</subject><subject>Original Research</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Right heart ventricle</subject><subject>Right ventricle</subject><subject>RV MPI</subject><subject>RV S</subject><subject>Stroke Volume</subject><subject>Systole</subject><subject>systolic function</subject><subject>TAPSE</subject><subject>Teaching hospitals</subject><subject>Ultrasonic imaging</subject><subject>Ventricular Dysfunction, Right - diagnosis</subject><subject>Ventricular Dysfunction, Right - epidemiology</subject><subject>Ventricular Dysfunction, Right - physiopathology</subject><subject>Ventricular Function, Left</subject><subject>Ventricular Function, Right</subject><issn>1178-2048</issn><issn>1176-6344</issn><issn>1178-2048</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptktuLEzEUxgdR3HX1zWcZEMQHW3OdTF6Esqi7sCKsl9eQyZy0KWlSk5lC_3szti6tSB4STn75ci5fVb3EaE4wE-9_3tx_mX_DjDAiH1WXGIt2RhBrH5-cL6pnOa8R4k2L8NPqgkhEKRftZbW4d8vVUO8gDMmZ0etU530eonemtmMwg4uhdqFe7beQBgjZ7aBegU5DbbXzY4Ln1ROrfYYXx_2q-vHp4_frm9nd18-314u7meGiGWaYW6Fb29EGN1wyS3VDwPZIEGF62UmmeSdQp0tqPcgeDO046YTEHIGWjNCr6vag20e9VtvkNjrtVdRO_QnEtFQlK2c8KMYb02sjeuAd65hokZWEUmo1xiA0LlofDlrbsdtAb6bqtT8TPb8JbqWWcad4Q1qBUBF4exRI8dcIeVAblw14rwPEMSssOeYNJVIU9PU_6DqOKZRWKUIKgIUUJ9RSlwJcsLH8ayZRteCUM4IkloWa_4cqq4eNMzGAdSV-9uDNyYMyNz-scvTjNNZ8Dr47gCbFnBPYh2ZgpCafqcln6uizgr86beAD_NdY9DcaQ8wn</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Oketona, O A</creator><creator>Balogun, M O</creator><creator>Akintomide, A O</creator><creator>Ajayi, O E</creator><creator>Adebayo, R A</creator><creator>Mene-Afejuku, T O</creator><creator>Oketona, O T</creator><creator>Bamikole, O J</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9107-8476</orcidid><orcidid>https://orcid.org/0000-0001-5205-9344</orcidid><orcidid>https://orcid.org/0000-0003-4993-0789</orcidid></search><sort><creationdate>20170101</creationdate><title>Right ventricular systolic function in hypertensive heart failure</title><author>Oketona, O A ; Balogun, M O ; Akintomide, A O ; Ajayi, O E ; Adebayo, R A ; Mene-Afejuku, T O ; Oketona, O T ; Bamikole, O J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Beta blockers</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Case-Control Studies</topic><topic>Complications and side effects</topic><topic>Cross-Sectional Studies</topic><topic>Development and progression</topic><topic>Echocardiography</topic><topic>Echocardiography, Doppler</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Health care</topic><topic>Heart failure</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - epidemiology</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - diagnostic imaging</topic><topic>Hypertension - epidemiology</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Medical examination</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Morphology</topic><topic>Nigeria - epidemiology</topic><topic>Original Research</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Right heart ventricle</topic><topic>Right ventricle</topic><topic>RV MPI</topic><topic>RV S</topic><topic>Stroke Volume</topic><topic>Systole</topic><topic>systolic function</topic><topic>TAPSE</topic><topic>Teaching hospitals</topic><topic>Ultrasonic imaging</topic><topic>Ventricular Dysfunction, Right - diagnosis</topic><topic>Ventricular Dysfunction, Right - epidemiology</topic><topic>Ventricular Dysfunction, Right - physiopathology</topic><topic>Ventricular Function, Left</topic><topic>Ventricular Function, Right</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oketona, O A</creatorcontrib><creatorcontrib>Balogun, M O</creatorcontrib><creatorcontrib>Akintomide, A O</creatorcontrib><creatorcontrib>Ajayi, O E</creatorcontrib><creatorcontrib>Adebayo, R A</creatorcontrib><creatorcontrib>Mene-Afejuku, T O</creatorcontrib><creatorcontrib>Oketona, O T</creatorcontrib><creatorcontrib>Bamikole, O J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Vascular health and risk management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oketona, O A</au><au>Balogun, M O</au><au>Akintomide, A O</au><au>Ajayi, O E</au><au>Adebayo, R A</au><au>Mene-Afejuku, T O</au><au>Oketona, O T</au><au>Bamikole, O J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Right ventricular systolic function in hypertensive heart failure</atitle><jtitle>Vascular health and risk management</jtitle><addtitle>Vasc Health Risk Manag</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>13</volume><spage>353</spage><epage>360</epage><pages>353-360</pages><issn>1178-2048</issn><issn>1176-6344</issn><eissn>1178-2048</eissn><abstract>Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor of adverse outcomes in HF. This study aimed to determine the prevalence of RV systolic dysfunction in HHF by several echocardiographic parameters.
One hundred subjects with HHF were recruited consecutively into the study along with 50 age and sex-matched controls. All study participants gave written informed consent, and had a full physical examination, blood investigations, 12-lead electrocardiogram, and transthoracic echocardiography. RV systolic function was assessed in all subjects using different methods based on the American Society of Echocardiography guidelines for echocardiographic assessment of the right heart in adults. This included tricuspid annular plane systolic excursion (TAPSE), RV myocardial performance index (MPI), and RV systolic excursion velocity by tissue Doppler (S').
RV systolic dysfunction was found in 53% of subjects with HHF by TAPSE, 56% by RV MPI, and 48% by tissue Doppler systolic excursion S'. RV systolic dysfunction increased with reducing left ventricular ejection fraction (LVEF) in subjects with HHF.
A high proportion of subjects with HHF were found to have RV systolic functional abnormalities using TAPSE, RV MPI, and RV S'. Prevalence of RV systolic dysfunction increased with reducing LVEF.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>29033578</pmid><doi>10.2147/VHRM.S142429</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9107-8476</orcidid><orcidid>https://orcid.org/0000-0001-5205-9344</orcidid><orcidid>https://orcid.org/0000-0003-4993-0789</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1178-2048 |
ispartof | Vascular health and risk management, 2017-01, Vol.13, p.353-360 |
issn | 1178-2048 1176-6344 1178-2048 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_456cdac7de5b4b4780f92333fa11e7a1 |
source | Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central(OpenAccess) |
subjects | Aged Beta blockers Blood pressure Cardiovascular disease Care and treatment Case-Control Studies Complications and side effects Cross-Sectional Studies Development and progression Echocardiography Echocardiography, Doppler Electrocardiography Female Health care Heart failure Heart Failure - diagnosis Heart Failure - epidemiology Heart Failure - physiopathology Humans Hypertension Hypertension - diagnostic imaging Hypertension - epidemiology Hypertension - physiopathology Male Medical examination Medical prognosis Medicine Methods Middle Aged Morphology Nigeria - epidemiology Original Research Prevalence Prognosis Right heart ventricle Right ventricle RV MPI RV S Stroke Volume Systole systolic function TAPSE Teaching hospitals Ultrasonic imaging Ventricular Dysfunction, Right - diagnosis Ventricular Dysfunction, Right - epidemiology Ventricular Dysfunction, Right - physiopathology Ventricular Function, Left Ventricular Function, Right |
title | Right ventricular systolic function in hypertensive heart failure |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A46%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Right%20ventricular%20systolic%20function%20in%20hypertensive%20heart%20failure&rft.jtitle=Vascular%20health%20and%20risk%20management&rft.au=Oketona,%20O%20A&rft.date=2017-01-01&rft.volume=13&rft.spage=353&rft.epage=360&rft.pages=353-360&rft.issn=1178-2048&rft.eissn=1178-2048&rft_id=info:doi/10.2147/VHRM.S142429&rft_dat=%3Cgale_doaj_%3EA535420919%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229717977&rft_id=info:pmid/29033578&rft_galeid=A535420919&rfr_iscdi=true |